Variant report

Variant	nsv1029182
Chromosome Location	chr6:55910866-55991956
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:476)
CpG islands
(count:366)
Chromatin interactive
region (count:9)
LncRNA
region (count:4)
Mature miRNA
region (count: 0)
miRNA target
sites (count:3)

(count:476 , 50 per page) page: 1 2 3 4 5 6 7 ... 10

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	ARID3A	chr6:55965915-55966165	HepG2	liver:	n/a	n/a
2	ARID3A	chr6:55955812-55956335	HepG2	liver:	n/a	n/a
3	BACH1	chr6:55940906-55941201	K562	blood:	n/a	chr6:55941022-55941036
4	BACH1	chr6:55940817-55941220	H1-hESC	embryonic stem cell:	n/a	chr6:55941022-55941036
5	BCL3	chr6:55965783-55966341	A549	lung:	n/a	chr6:55966245-55966254
6	BHLHE40	chr6:55941016-55941166	K562	blood:	n/a	n/a
7	CBX3	chr6:55918563-55918866	HCT-116	colon:	n/a	n/a
8	CBX3	chr6:55955872-55956391	HCT-116	colon:	n/a	n/a
9	CBX3	chr6:55965751-55966236	HCT-116	colon:	n/a	n/a
10	CEBPB	chr6:55955880-55956451	HCT-116	colon:	n/a	n/a
11	CEBPB	chr6:55958661-55958977	HepG2	liver:	n/a	n/a
12	CEBPB	chr6:55955905-55956411	HepG2	liver:	n/a	n/a
13	CEBPB	chr6:55955918-55956243	ECC-1	luminal epithelium:	n/a	n/a
14	CEBPB	chr6:55965899-55966311	A549	lung:	n/a	n/a
15	CEBPB	chr6:55929926-55930126	A549	lung:	n/a	n/a
16	CEBPB	chr6:55955935-55956340	A549	lung:	n/a	n/a
17	CEBPB	chr6:55925803-55925911	H1-hESC	embryonic stem cell:	n/a	n/a
18	CEBPB	chr6:55965805-55966512	A549	lung:	n/a	n/a
19	CEBPB	chr6:55965830-55966418	Hela-S3	cervix:	n/a	n/a
20	CEBPB	chr6:55965807-55966379	HCT-116	colon:	n/a	n/a
21	CEBPB	chr6:55965942-55966320	HepG2	liver:	n/a	n/a
22	CEBPB	chr6:55965772-55966529	HCT-116	colon:	n/a	n/a
23	CEBPB	chr6:55965906-55966394	MCF-7	breast:	n/a	n/a
24	CEBPB	chr6:55955928-55956402	MCF-7	breast:	n/a	n/a
25	CEBPB	chr6:55965863-55966401	IMR90	lung:	n/a	n/a
26	CEBPB	chr6:55929954-55930109	Hela-S3	cervix:	n/a	n/a
27	CEBPB	chr6:55955868-55956375	MCF-7	breast:	n/a	n/a
28	CEBPB	chr6:55955967-55956204	HepG2	liver:	n/a	n/a
29	CEBPB	chr6:55965798-55966506	MCF-7	breast:	n/a	n/a
30	CEBPB	chr6:55947672-55947758	HepG2	liver:	n/a	chr6:55947712-55947723 chr6:55947712-55947725
31	CEBPB	chr6:55955928-55956299	IMR90	lung:	n/a	n/a
32	CEBPB	chr6:55965901-55966394	A549	lung:	n/a	n/a
33	CEBPB	chr6:55945797-55946082	IMR90	lung:	n/a	chr6:55945963-55945974
34	CEBPB	chr6:55945796-55946136	HepG2	liver:	n/a	chr6:55945963-55945974
35	CEBPB	chr6:55955928-55956302	Hela-S3	cervix:	n/a	n/a
36	CEBPB	chr6:55945805-55946109	A549	lung:	n/a	chr6:55945963-55945974
37	CEBPB	chr6:55966145-55966220	H1-hESC	embryonic stem cell:	n/a	n/a
38	CEBPB	chr6:55955903-55956318	ECC-1	luminal epithelium:	n/a	n/a
39	CEBPB	chr6:55955846-55956322	A549	lung:	n/a	n/a
40	CEBPB	chr6:55929895-55930181	HepG2	liver:	n/a	n/a
41	CTCF	chr6:55918600-55918750	AG04449	skin:	n/a	chr6:55918717-55918730
42	CTCF	chr6:55927880-55928030	AG09319	gingival:	n/a	chr6:55927903-55927912
43	CTCF	chr6:55927820-55927970	AoAF	blood vessel:	n/a	chr6:55927903-55927912
44	CTCF	chr6:55937289-55937305	Lung_OC	lung:	n/a	n/a
45	CTCF	chr6:55918620-55918770	SAEC	small airway:	n/a	chr6:55918717-55918730
46	CTCF	chr6:55945613-55945638	Lung_OC	lung:	n/a	n/a
47	CTCF	chr6:55927880-55928030	NHLF	lung:	n/a	chr6:55927903-55927912
48	CTCF	chr6:55918680-55918830	GM12870	blood:	n/a	chr6:55918717-55918730
49	CTCF	chr6:55916560-55916710	GM12872	blood:	n/a	n/a
50	CTCF	chr6:55918651-55918790	MCF-7	breast:	n/a	chr6:55918717-55918730

(count:366 , 50 per page) page: 1 2 3 4 5 6 7 8

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr6:55965977-55966027	NB4	blood:	n/a
2	chr6:55989734-55989784	HEEpiC	esophagus:	n/a
3	chr6:55921912-55921962	BE2_C	brain:	n/a
4	chr6:55956315-55956365	HRPEpiC	eye:	n/a
5	chr6:55977770-55977820	NHDF-neo	bronchial:	n/a
6	chr6:55956315-55956365	AG04449	skin:	fetal
7	chr6:55989097-55989147	ECC-1	luminal epithelium:	n/a
8	chr6:55977770-55977820	AG04449	skin:	fetal
9	chr6:55989097-55989147	Hela-S3	cervix:	n/a
10	chr6:55977770-55977820	HCPEpiC	choroid plexus:	n/a
11	chr6:55989734-55989784	H1-hESC	embryonic stem cell:	embryo
12	chr6:55989734-55989784	NHBE	bronchial:	n/a
13	chr6:55989734-55989784	HCPEpiC	choroid plexus:	n/a
14	chr6:55989097-55989147	GM19239	blood:	n/a
15	chr6:55989734-55989784	BJ	skin:	n/a
16	chr6:55977770-55977820	HCF	heart:	n/a
17	chr6:55977770-55977820	GM06990	blood:	n/a
18	chr6:55921912-55921962	ovcar-3	ovarian:	n/a
19	chr6:55977770-55977820	SK-N-MC	brain:	n/a
20	chr6:55989097-55989147	NB4	blood:	n/a
21	chr6:55921912-55921962	HNPCEpiC	eye:	n/a
22	chr6:55921912-55921962	U87	brain:	n/a
23	chr6:55977770-55977820	NT2-D1	testis:	n/a
24	chr6:55956315-55956365	AG09309	skin:	n/a
25	chr6:55956315-55956365	HCT-116	colon:	n/a
26	chr6:55965977-55966027	PrEC	prostate:	n/a
27	chr6:55977770-55977820	SK-N-SH_RA	brain:	n/a
28	chr6:55921912-55921962	HL-60	blood:	n/a
29	chr6:55965977-55966027	SK-N-SH	brain:	n/a
30	chr6:55956315-55956365	HEEpiC	esophagus:	n/a
31	chr6:55965977-55966027	MCF10A-Er-Src	breast:	n/a
32	chr6:55921912-55921962	AoSMC	blood vessel:	n/a
33	chr6:55965977-55966027	HRE	kidney:	n/a
34	chr6:55956315-55956365	NB4	blood:	n/a
35	chr6:55956315-55956365	PANC-1	pancreas:	n/a
36	chr6:55965977-55966027	HCF	heart:	n/a
37	chr6:55965977-55966027	T-47D	breast:	n/a
38	chr6:55977770-55977820	SKMC	muscle:	n/a
39	chr6:55965977-55966027	LNCaP	prostate:	n/a
40	chr6:55956315-55956365	HAEpiC	amniotic membrane:	n/a
41	chr6:55965977-55966027	SAEC	small airway:	n/a
42	chr6:55956315-55956365	GM19239	blood:	n/a
43	chr6:55956315-55956365	A549	lung:	n/a
44	chr6:55965977-55966027	HepG2	liver:	n/a
45	chr6:55989734-55989784	HCT-116	colon:	n/a
46	chr6:55989734-55989784	NB4	blood:	n/a
47	chr6:55965977-55966027	HCT-116	colon:	n/a
48	chr6:55989734-55989784	MCF10A-Er-Src	breast:	n/a
49	chr6:55989734-55989784	AG04450	lung:	fetal
50	chr6:55989734-55989784	A549	lung:	n/a

(count:9 , 50 per page) page: 1

No.	Distal block	Cell Line	Cell type
1	chr6:55964932..55967397-chr6:55975389..55977144,2	MCF-7	breast:
2	chr6:55932576..55934705-chr6:55937943..55940116,3	K562	blood:
3	chr22:21977904..21980225-chr6:55963610..55966434,2	MCF-7	breast:
4	chr6:55904181..55905774-chr6:55908809..55911144,2	MCF-7	breast:
5	chr6:55926997..55929020-chr6:55932279..55934927,2	MCF-7	breast:
6	chr6:55926997..55929020-chr6:55932279..55934927,2	MCF-7	breast:
7	chr6:55964932..55967397-chr6:55975389..55977144,2	MCF-7	breast:
8	chr6:55886603..55887384-chr6:55918244..55919071,2	MCF-7	breast:
9	chr6:55932576..55934705-chr6:55937943..55940116,3	K562	blood:

(count:4 , 50 per page) page: 1

No.	lncRNA name	Chromosome Location	lncRNA alias
1	lnc-BMP5-2	chr6:55956295-55956486	NONHSAT113238
2	lnc-BMP5-3	chr6:55990894-55991441	NONHSAT113239
3	lnc-BMP5-2	chr6:55955608-55955711	NONHSAT113238
4	lnc-BMP5-3	chr6:55990189-55990418	NONHSAT113239

No data

(count:3 , 50 per page) page: 1

No.	miRNA target gene	miRNA name	Chromosome Location
1	COL21A1	hsa-miR-29c-3p	chr6:55922417-55922438
2	COL21A1	hsa-miR-29c-3p	chr6:55922423-55922417
3	COL21A1	hsa-miR-29c-3p	chr6:55921829-55921850

Variant related genes	Relation type
COL21A1	TF binding region
COL21A1	CpG island

Extended variants
information (count: 3046 )
Associated
traits (count: 83 )

Variant overlapped rSNPs/rCNVs (count:3046 , 50 per page) page: 1 2 3 4 5 6 7 ... 61

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs549446645	chr6:55910901-55910902	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
2	rs537800179	chr6:55910917-55910918	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
3	rs80116015	chr6:55910942-55910943	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
4	rs9475548	chr6:55910991-55910992	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
5	rs140771994	chr6:55910992-55910993	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
6	rs371126761	chr6:55910995-55910996	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
7	rs373778671	chr6:55911019-55911020	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
8	rs13190797	chr6:55911033-55911034	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
9	rs182408271	chr6:55911054-55911055	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
10	rs538246991	chr6:55911079-55911080	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
11	rs386407150	chr6:55911080-55911081	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
12	rs201201227	chr6:55911092-55911093	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
13	rs185401984	chr6:55911110-55911111	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
14	rs576946500	chr6:55911111-55911112	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
15	rs190608032	chr6:55911142-55911143	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
16	rs562398331	chr6:55911190-55911191	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
17	rs183661133	chr6:55911255-55911256	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
18	rs200712170	chr6:55911270-55911271	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
19	rs541888891	chr6:55911279-55911280	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
20	rs376328542	chr6:55911281-55911282	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
21	rs561666431	chr6:55911304-55911305	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
22	rs545614705	chr6:55911316-55911317	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
23	rs530448033	chr6:55911352-55911353	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
24	rs114414153	chr6:55911430-55911431	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
25	rs73457043	chr6:55911431-55911432	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
26	rs532566822	chr6:55911456-55911457	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
27	rs62406124	chr6:55911470-55911471	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
28	rs569212039	chr6:55911480-55911481	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
29	rs543277928	chr6:55911496-55911497	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
30	rs537938338	chr6:55911527-55911528	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
31	rs554590563	chr6:55911567-55911568	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
32	rs9475549	chr6:55911576-55911577	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
33	rs533869328	chr6:55911621-55911622	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
34	rs553754890	chr6:55911623-55911624	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
35	rs576971174	chr6:55911674-55911675	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
36	rs188814911	chr6:55911686-55911687	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
37	rs556315145	chr6:55911708-55911709	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
38	rs576105777	chr6:55911718-55911719	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
39	rs62406125	chr6:55911740-55911741	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
40	rs541927567	chr6:55911741-55911742	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
41	rs576649803	chr6:55911742-55911743	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
42	rs527248050	chr6:55911760-55911761	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
43	rs201566981	chr6:55911843-55911844	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
44	rs34081671	chr6:55911857-55911858	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
45	rs370364712	chr6:55911863-55911864	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
46	rs76543368	chr6:55911871-55911872	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
47	rs9382576	chr6:55911927-55911928	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
48	rs13194761	chr6:55911932-55911933	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
49	rs75167203	chr6:55911936-55911937	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
50	rs147428811	chr6:55911964-55911965	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a

Variant related diseases (count:83)

Disease	PMID	Source
Basal cell lymphoma	16317097	CNVD
Diffuse large b-cell lymphoma	16317097	CNVD
Leukemia	21518781	CNVD
Cancer	21637783	CNVD
Facial dysmorphism	22105932	CNVD
Medulloblastoma	21979893	CNVD
Non-syndromic sensorineural hearing loss	18471307	CNVD
Diffuse large b-cell lymphoma	18287131	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Glioblastoma multiforme	19960244	CNVD
Glioblastoma multiforme	21080181	CNVD
Hepatocellular carcinoma	22174799	CNVD
Endometrial cancer	22040021	CNVD
Acute myeloid leukemia	16864856	CNVD
Breast cancer	21264507	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Cancer	16751803	CNVD
Bladder cancer	19088036	CNVD
Wilms tumour	21544195	CNVD
Uveal melanoma	21693616	CNVD
Biliary cancer	19435499	CNVD
Malaria	21533027	CNVD
Retinoblastoma	19183342	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Breast cancer	21858162	CNVD
Ewing''s sarcoma	17952124	CNVD
Autism	21448237	CNVD
Breast cancer	20668451	CNVD
Cancer	20668451	CNVD
Lung cancer	20668451	CNVD
Ovarian cancer	20668451	CNVD
Pancreas cancer	20668451	CNVD
Prostate cancer	20668451	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Autism	22495311	CNVD
Endometrioid adenocarcinoma	16974079	CNVD
Urothelial carcinoma	18382360	CNVD
Cancer	21183584	CNVD
small cell lung cancer	20016488	CNVD
Gastric cancer	17908304	CNVD
Malignant peripheral nerve sheath tumor	18522746	CNVD
Neuroblastoma	16790693	CNVD
T-cell prolymphocytic leukemia	17713554	CNVD
Osteosarcoma	16790693	CNVD
Biliary cancer	20360734	CNVD
Breast cancer	20360734	CNVD
Coronary artery disease	20360734	CNVD
Crohn''s disease	20360734	CNVD
Hypertension	20360734	CNVD
Rheumatoid arthritis	20360734	CNVD
Type 1 diabetes	20360734	CNVD
Type 2 diabetes	20360734	CNVD
Acute lymphoblastic leukemia	22237106	CNVD
Lung cancer	18438408	CNVD
Neuroblastoma	18923191	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Breast cancer	17603634	CNVD
Neurocytoma	17123091	CNVD
Systemic lupus erythematosus	17503323	CNVD
Gastrointestinal stromal cancer	20818650	CNVD
Breast cancer	16608533	CNVD
Melanoma	18172304	CNVD
Esophageal adenocarcinoma	18820669	CNVD
Neuroblastoma	19686582	CNVD
Neuroblastoma	17289879	CNVD
Breast cancer	17899364	CNVD
Breast cancer	17133270	CNVD
Esophageal squamous carcinoma	18350619	CNVD
Chronic lymphocytic leukemia	20421269	CNVD
Myelofibrosis	22110671	CNVD
Glioblastoma multiforme	22286061	CNVD
Colorectal cancer	16912164	CNVD
Colorectal cancer	16272173	CNVD
Breast cancer	21364760	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
Acute lymphoblastic leukemia	18458336	CNVD
Breast cancer	21509527	CNVD
lymphocytic leukemia	21291569	CNVD
Non-syndromic sensorineural hearing loss	18451855	CNVD
Breast cancer	22522925	CNVD
Non-syndromic sensorineural hearing loss	21293372	CNVD
Medulloblastoma	21163964	CNVD
Non-syndromic sensorineural hearing loss	22037309	CNVD

Chromatin state (count:439 , 50 per page) page: 1 2 3 4 5 6 7 ... 9

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr6:55899200-55920400	Weak transcription	Fetal Muscle Leg	muscle
2	chr6:55905800-55911600	Weak transcription	Breast variant Human Mammary Epithelial Cells (vHMEC)	Breast
3	chr6:55910600-55911200	Bivalent Enhancer	Primary hematopoietic stem cells G-CSF-mobilized Male	--
4	chr6:55910600-55913800	Enhancers	HUVEC	blood vessel
5	chr6:55910600-55915600	Enhancers	Bone Marrow Derived Cultured Mesenchymal Stem Cells	Bone marrow
6	chr6:55910600-55915800	Enhancers	Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells	embryonic stem cell
7	chr6:55910800-55911000	Bivalent Enhancer	Primary hematopoietic stem cells G-CSF-mobilized Female	--
8	chr6:55910800-55911000	Enhancers	HSMMtube	muscle
9	chr6:55910800-55911200	Bivalent Enhancer	Primary monocytes fromperipheralblood	blood
10	chr6:55910800-55912000	Enhancers	HSMM	muscle
11	chr6:55910800-55914200	Weak transcription	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
12	chr6:55910800-55916000	Enhancers	Osteobl	bone
13	chr6:55910800-55916400	Enhancers	Muscle Satellite Cultured Cells	--
14	chr6:55911000-55911200	Bivalent Enhancer	Monocytes-CD14+_RO01746	blood
15	chr6:55911000-55912000	Enhancers	Primary hematopoietic stem cells short term culture	blood
16	chr6:55911000-55912200	Enhancers	Primary hematopoietic stem cells	blood
17	chr6:55911000-55912400	Enhancers	Primary hematopoietic stem cells G-CSF-mobilized Female	--
18	chr6:55911200-55911400	Enhancers	Primary hematopoietic stem cells G-CSF-mobilized Male	--
19	chr6:55911200-55911400	Enhancers	Monocytes-CD14+_RO01746	blood
20	chr6:55911200-55911600	Enhancers	NH-A	brain
21	chr6:55911200-55912000	Enhancers	Foreskin Melanocyte Primary Cells skin03	Skin
22	chr6:55911200-55912000	Enhancers	HMEC	breast
23	chr6:55911200-55912200	Enhancers	Primary monocytes fromperipheralblood	blood
24	chr6:55911400-55911800	Enhancers	Primary neutrophils fromperipheralblood	blood
25	chr6:55911400-55911800	Enhancers	Left Ventricle	heart
26	chr6:55911400-55912000	Flanking Active TSS	Primary hematopoietic stem cells G-CSF-mobilized Male	--
27	chr6:55911400-55912200	Flanking Active TSS	Monocytes-CD14+_RO01746	blood
28	chr6:55911600-55912000	Enhancers	H1 Derived Mesenchymal Stem Cells	ES cell derived
29	chr6:55911600-55912400	Enhancers	Breast variant Human Mammary Epithelial Cells (vHMEC)	Breast
30	chr6:55911800-55940800	Weak transcription	Left Ventricle	heart
31	chr6:55912000-55912400	Bivalent Enhancer	Primary hematopoietic stem cells G-CSF-mobilized Male	--
32	chr6:55912200-55912400	Enhancers	Monocytes-CD14+_RO01746	blood
33	chr6:55912200-55915200	Weak transcription	Primary monocytes fromperipheralblood	blood
34	chr6:55912400-55913200	Weak transcription	Breast variant Human Mammary Epithelial Cells (vHMEC)	Breast
35	chr6:55912400-55915400	Weak transcription	Monocytes-CD14+_RO01746	blood
36	chr6:55913000-55913200	Enhancers	H9 Derived Neuron Cultured Cells	ES cell derived
37	chr6:55913000-55913600	Enhancers	Foreskin Fibroblast Primary Cells skin01	Skin
38	chr6:55913200-55913400	Enhancers	ES-I3 Cell Line	embryonic stem cell
39	chr6:55913200-55913400	Enhancers	Breast variant Human Mammary Epithelial Cells (vHMEC)	Breast
40	chr6:55913200-55914200	Weak transcription	H9 Derived Neuron Cultured Cells	ES cell derived
41	chr6:55913400-55915800	Weak transcription	ES-I3 Cell Line	embryonic stem cell
42	chr6:55914200-55914800	Enhancers	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
43	chr6:55914200-55916400	Enhancers	H9 Derived Neuron Cultured Cells	ES cell derived
44	chr6:55914800-55915200	Weak transcription	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
45	chr6:55915200-55915400	Enhancers	Fetal Heart	heart
46	chr6:55915200-55916200	Enhancers	H9 Derived Neuronal Progenitor Cultured Cells	ES cell derived
47	chr6:55915200-55916200	Enhancers	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
48	chr6:55915200-55917000	Enhancers	Primary monocytes fromperipheralblood	blood
49	chr6:55915400-55915800	Bivalent Enhancer	Primary hematopoietic stem cells G-CSF-mobilized Male	--
50	chr6:55915400-55916000	Weak transcription	Fetal Heart	heart

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links